AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2012
Feb 22, 2012
29875_dirs_2012-02-22_5736959f-d990-4eda-80ff-bb8c3ead8777.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2012-02-21
Reporting Person: Brennan Troyen A (EVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-21 | Common Stock | M | 96354 | $28.10 | Acquired | 112818.1987 | Direct |
| 2012-02-21 | Common Stock | S | 96354 | $44.03 | Disposed | 16464.1987 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-21 | Stock Option | $28.10 | M | 96354 | Disposed | 2016-04-01 | Common Stock (96354) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (pep) | 11027.1987 | Direct |
| Common Stock (restricted) | 48937 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $36.23 | 2017-04-01 | Common Stock (103267) | 103267 | Direct |
| Stock Option | $28.26 | 2018-11-17 | Common Stock (106160) | 106160 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (66987) | 66987 | Direct |
Footnotes
F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $44.01 and $44.08 per share.
F2: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F3: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F4: Option became exercisable in three equal annual installments, commencing 11/17/2011.
F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3